Sinovac Biotech Ltd (NASDAQ:SVA)

5.24
Delayed Data
As of Jul 01
 -0.01 / -0.19%
Today’s Change
4.51
Today|||52-Week Range
6.03
+0.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-399.7K-14.9M4.5M-336.0K
 
 
 
 
 
Depreciation4.8M4.5M6.7M8.4M
 
 
 
 
 
Total Other Cash Flow3.8M998.4K9.5M2.0M
 
 
 
 
 
Funds From Operations11.1M-9.4M18.5M9.9M
 
 
 
 
 
Funds From/For Other Operating Expenses-2.9M6.9M12.9M18.5M
 
 
 
 
 
Net Cash Flow - Operating Activities13.9M-16.3M5.6M-8.6M
 
 
 
 
 
 
InvestingDecrease In Investments1.5M0.000.000.00
 
 
Capital Expenditures-15.5M-16.2M-5.2M-11.0M
 
 
 
 
 
Fixed Asset Disposal122.1K5.4K0.000.00
 
 
 
Net Cash Flow Investing-13.8M-16.2M-5.2M-11.0M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings11.4M16.8M16.8M17.8M
 
 
 
 
 
Long Term Debt Reduction-10.7M-4.8M-4.1M-16.6M
 
 
 
 
 
Net Proceeds Stock Sale752.2K515.7K848.0K512.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing5.0M5.6M860.0K3.6M
 
 
 
 
 
Other Uses - Financing5.9M802.2K0.000.00
 
 
 
Net Cash Flow - Financing612.9K17.3M14.4M5.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash1.9M2.0M1.2M-1.4M
 
 
 
 
 
 
Net Change In Cash758.4K-15.1M14.8M-14.3M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account